首页> 外文期刊>Veterinary Research Communications >Effectiveness of different avian influenza (H5) vaccination regimens in layer chickens on the humoral immune response and interferonalpha signalling immune marker
【24h】

Effectiveness of different avian influenza (H5) vaccination regimens in layer chickens on the humoral immune response and interferonalpha signalling immune marker

机译:不同禽流感(H5)疫苗接种方案对体液免疫应答和干扰素信号免疫标志物

获取原文
获取原文并翻译 | 示例
       

摘要

Avian influenza (AI) vaccines are widely used to control and eliminate the ongoing avian influenza virus epidemic in Egypt. A strict vaccination policy with inactivated AI vaccines has been widely applied, however the virus still circulating, evolving and causing great negative impact to the poultry sector in Egypt. Therefore, an updated poultry vaccination policy using different vaccine technologies might be valuable as an innovative additional control strategy of AIV in Egypt. In the present study, the effectiveness of different avian influenza (AI) vaccination schedules was evaluated in 300 commercial layer chicks (ISA White) using either the oil-emulsion baculovirus-H5-prototype vaccine (baculovirus-H5 prototype) or turkey herpesvirus (HVT) vector vaccine containing the hemagglutinin (HA) gene from H5N1 strain (rHVT-H5), applied alone or in combination and in different settings. Vaccination with either two injections of the baculovirus-H5 prototype, a single injection of rHVT-H5 or priming with rHVT-H5 at 1 day old followed by boosting with the baculovirus-H5 prototype induced AI-HI protective antibody responses starting as early as 3 to 4 weeks of age and lasting up to the end of the rearing period (16 weeks). A single vaccination with the baculovirus-H5 prototype did not generate a protective antibody titre for the entire rearing period. Furthermore, the present study elucidated that vaccination once or twice with the baculovirus-H5 vaccine prototype activated the chicken interferon-alpha (Ch-IFN-alpha) signalling pathway via transduction of antiviral components, e.g., Mx1 and IRF7. Birds immunized once with rHVT-H5 at 1 day old did not show activation of the Mx1 and IRF7 transcripts; however, following boosting with the baculovirus-H5 prototype vaccine, up-regulation of Mx1 and IRF7 was observed. Based on our findings, it can be concluded that either reinforcement with two injections of the baculovirus-H5 prototype or prime-boost vaccination (rHVT-H5 at 1 day old followed by the baculovirus-H5 prototype vaccine at 8 days old) is a successful strategy to induce both innate and humoral immune responses and could be recommended for the layer production sector over the entire rearing period, especially in Al-endemic areas.
机译:禽流感(AI)疫苗被广泛用于控制和消除埃及的正在进行的禽流感病毒流行病。具有灭活AI疫苗的严格疫苗接种政策已被广泛应用,但病毒仍在循环,不断发展和对埃及家禽行业产生巨大的负面影响。因此,使用不同疫苗技术的更新的家禽疫苗接种政策可能是埃及AIV的创新额外控制策略。在本研究中,使用油乳液Baculovirus-H5 - 原型疫苗(Baculovirus-H5原型)或土耳其疱疹病毒(HVT )载体含有来自H5N1菌株(RHVT-H5)的血凝素(HA)基因的疫苗,单独或组合施用和不同的环境。用两次注射杆状病毒 - H5原型的疫苗接种,一次注射rHVT-H5或用rHVT-H5引发1天,然后用杆状病毒-H5原型诱导诱导的AI-HI保护抗体反应,早在3到4周龄,持续到饲养期结束(16周)。用杆状病毒-H5原型的单一疫苗接种未产生整个饲养期的保护性抗体滴度。此外,本研究阐明了用杆状病毒-H5疫苗原型的一次或两次疫苗接种,通过转导抗病毒组分,例如MX1和IRF7,活化鸡干扰素-α(CH-IFN-α)信号传导途径。用rhVT-H5免疫鸟类在1天的rhVT-H5免疫,未显示MX1和IRF7转录物的激活;然而,随后用杆状病毒-H5原型疫苗,观察到MX1和IRF7的上调。基于我们的研究结果,可以得出结论,两次注射杆状病毒-H5原型或素增压疫苗接种(1天的Rhvt-H5,其次是杆状病毒-H5在8天大的原型疫苗)是一个成功的在整个饲养期间诱导天生和体液免疫反应的策略,可以在整个饲养期间推荐用于层生产部门,特别是在AL-流行区域。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号